open access

Vol 7, No 2 (2016)
Review paper
Published online: 2016-11-09
Get Citation

Morbidity and mortality of patients with chronic lymphocytic leukemia in Poland between 1999 and 2013

Joanna Didkowska, Urszula Wojciechowska, Jakub Gierczyński, Krzysztof Warzocha, Ewa Lech-Marańda
DOI: 10.5603/Hem.2016.0013
·
Hematologia 2016;7(2):108-116.

open access

Vol 7, No 2 (2016)
REVIEW ARTICLES
Published online: 2016-11-09

Abstract

Chronic lymphocytic leukemia (CLL) is a cancer that is epidemiologically difficult to describe arising from the definition of the blood cancers adopted in the 10th Revision of the International Statistical Classification of Diseases and Related Health Problems. In Poland CLL cases accounted for 1.3% and 1% in men and 1 women respectively in 2013 (1.2% and 0.9% of deaths). The incidence for men was 3.3/100,000 and 1.7/100,000 in women (mortality rates being 1.8/100,000 and 0.7/100,000 respectively). In Poland, the median patient’s age is 69 years. Indicators of 5-year relative survival for patients diagnosed in 2006–2009 were 55.8% for men and 68.1% for women.

Abstract

Chronic lymphocytic leukemia (CLL) is a cancer that is epidemiologically difficult to describe arising from the definition of the blood cancers adopted in the 10th Revision of the International Statistical Classification of Diseases and Related Health Problems. In Poland CLL cases accounted for 1.3% and 1% in men and 1 women respectively in 2013 (1.2% and 0.9% of deaths). The incidence for men was 3.3/100,000 and 1.7/100,000 in women (mortality rates being 1.8/100,000 and 0.7/100,000 respectively). In Poland, the median patient’s age is 69 years. Indicators of 5-year relative survival for patients diagnosed in 2006–2009 were 55.8% for men and 68.1% for women.

Get Citation

Keywords

incidence, mortality, chronic lymphocytic leukemia

About this article
Title

Morbidity and mortality of patients with chronic lymphocytic leukemia in Poland between 1999 and 2013

Journal

Hematology in Clinical Practice

Issue

Vol 7, No 2 (2016)

Article type

Review paper

Pages

108-116

Published online

2016-11-09

DOI

10.5603/Hem.2016.0013

Bibliographic record

Hematologia 2016;7(2):108-116.

Keywords

incidence
mortality
chronic lymphocytic leukemia

Authors

Joanna Didkowska
Urszula Wojciechowska
Jakub Gierczyński
Krzysztof Warzocha
Ewa Lech-Marańda

References (10)
  1. Didkowska J, Wojciechowska U. Nowotwory złośliwe w Polsce w 2013 roku. . Centrum Onkologii — Instytut im. M. Skłodowskiej-Curie, Warszawa 2015.
  2. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982; 38(4): 933–942.
  3. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer. 2004; 40(15): 2307–2316.
  4. Association of Population-based Cancer Registries in Germany (GEKID). http://www.gekid.de/index_e.html (07.04.2016).
  5. Chronic lymphocytic leukaemia (CLL) statistics. Cancer Research UK. http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/leukaemiacll (30.04.2016).
  6. What are the key statistics for chronic lymphocytic leukemia? American Cancer Society’s Cancer Statistics Center. http://www.cancer.org/cancer/leukemia-chroniclymphocyticcll/detailedguide/leukemia-chronic-lymphocytic-key-statistics (30.04.2016).
  7. Redaelli A, Laskin BL, Stephens JM, et al. The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care (Engl). 2004; 13(3): 279–287.
  8. SEER Stat Fact Sheets: Chronic Lymphocytic Leukemia (CLL). Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI). http://seer.cancer.gov/statfacts/html/clyl.html (30.04.2016).
  9. Sant M, Minicozzi P, Mounier M, et al. EUROCARE-5 Working Group. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. 2014; 15(9): 931–942.
  10. Panovská A, Doubek M, Brychtová Y, et al. Chronic lymphocytic leukemia and focusing on epidemiology and management in everyday hematologic practice: recent data from the Czech Leukemia Study Group for Life (CELL). Clin Lymphoma Myeloma Leuk. 2010; 10(4): 297–300.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.